Orchid Pharma Approves Enabling Resolution to Raise up to Rs. 600 Crore
Orchid Pharma Ltd 路 Others (Uncategorized) 路 20 Oct 2026, 5:52 pm
Orchid Pharma Approves Enabling Resolution to Raise up to Rs. 600 Crore The Board of Directors of Orchid Pharma Limited, at its meeting held on 20th Oct'26, approved an enabling resolution to explore fundraising of up to Rs. 600 crore. The capital may be raised through equity shares, convertible debentures, or other eligible securities via Qualified Institutions Placement (QIP), preferential issue, private placement, public issue, or other permissible modes, subject to requisite shareholder and regulatory approvals. Specific issuance structures and terms remain to be finalized.
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') 路 18 Nov 2026
- Board Comments on fine levied by Stock Exchanges 路 17 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 路 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) 路 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 路 14 Nov 2026
